This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Brazil CADE's investigatory unit recommends blocking Unimed-Gerdau health service deal

( June 3, 2024, 18:12 GMT | Official Statement) -- MLex Summary: Brazilian competition authority investigators said a health services deal between health plan operator Unimed and steelmaker Gerdau Açominas should be blocked. The transaction involves Unimed's planned investment in Fundação Ouro Branco, a healthcare service provider controlled by Gerdau. CADE's Superintendence sent the deal to the agency's Tribunal after finding vertical concerns with the transaction and no feasible remedies to address potential competition concerns.See full statement in Portuguese....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login